A Rare Case of Recurrent Pituitary Collision Tumors
Author(s) -
Almoutaz Shakally,
Naoyuki Tahara,
Brent Clark,
Ramachandra P. Tummala,
Emiro CaicedoGranados,
Yasuhiko Kawakami,
Takako Araki
Publication year - 2020
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvaa089
Subject(s) - craniopharyngioma , pituitary adenoma , wnt signaling pathway , cancer research , medicine , pituitary neoplasm , pituitary tumors , pathology , pituitary gland , adenoma , endocrinology , biology , signal transduction , microbiology and biotechnology , hormone
Pituitary collision tumors are sporadically reported and rare. We present a case of pituitary collision tumors with nonfunctioning pituitary adenoma (NFPA) and craniopharyngioma. In order to look for any common activated pathway, we examined WNT/β-CATENIN signaling activation, known to be involved in tumorigenesis in both craniopharyngioma and NFPA. We found nuclear accumulation of β-CATENIN protein and expression of LEF1 protein, markers of active β-CATENIN signaling in the craniopharyngioma but not in the pituitary adenomas. In our case, the NFPA is invasive macroadenoma, which is a frequently identified type of pituitary adenoma in collision tumor cases. Recurrence of this tumor was first observed after 8 years of follow-up. Based on this case, we suggest that pituitary collision tumors require long-term follow-up.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom